Becton, Dickinson and Co. (BDX) said Wednesday it plans to increase capacity for critical medical devices by making new investments in its manufacturing facilities in the US.
The company intends to invest more than $30 million this year to increase manufacturing capacity for IV lines at its Utah plant.
Becton, Dickinson said it installed new needle and syringe production lines at its plants in Connecticut and Nebraska as part of its 2024 investment of more than $10 million. One line is now fully operational, while additional lines are likely to start up in the coming months, the company said.
Price: 235.45, Change: -0.35, Percent Change: -0.15
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.